Ex-IPS officer and Bharat Rashtra Samithi (BRS) leader RS Praveen Kumar filed a formal complaint against CM Revanth Reddy for Formula-E cancellation A former Indian Police Service (IPS ...

Bharat Rashtra Samithi (BRS) leader and former IPS officer R. S. Praveen Kumar on Tuesday lodged a police complaint against Chief Minister A. Revanth Reddy in Formula-E car race case. Praveen Kumar ...

Dr. Reddy's Laboratories Ltd. 500124 shares slipped 1.47% to 1,179.85 Indian rupees Tuesday, on what proved to be an all-around great trading session for the stock market, with the BSE SENSEX ...

On what sets Telangana apart, Reddy mentioned amendments to investment policies and focusses on areas like green energy, defence, AI, and quantum computing. “For example, three COVID-19 vaccines were ...

Hyderabad: An attempt by Chief Minister A Revanth Reddy to snub BRS working president and former IT Minister KT Rama Rao by labelling him an IT employee with a “worker’s mindset” is fast boomeranging, ...

Reddy Customs, an automotive customization company, introduced four vehicle modifications at the Bharat Mobility Global Expo 2025 in New Delhi. The showcase includes a Mercedes G-Wagon, a Mercedes ...

Indian pharmaceutical major, Dr Reddy’s Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025. According ...

She claimed that on Saturday, the board carrying Anil Reddy’s name was replaced with another board bearing YouTuber G. Narasimha Reddy’s name as owner. Countering the complaint, Shaik Jameel ...

Complaint filed against Telangana Congress leader's relative YouTuber G Narasimha Reddy named in land ownership claim Counter-complaint alleges political misuse A land dispute involving YSR Congress ...

In a dramatic turn of events, Gajjala Narasimha Reddy, a close aide of Telangana Congress chief minister Revanth Reddy, and Anil Reddy, brother-in-law of former minister Damodar Rajanarasimha, have ...

BofA has chosen Dr. Reddy's Laboratories Ltd. as its top pick in the Indian pharma space, as its sees earnings visibility in the near term. Two years of outperformance-boosted valuation and gross ...